换一批
换一批A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil.
作者：
主题词
成年人(Adult);老年人(Aged);抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);综合疗法(Combined Modality Therapy);二氢尿嘧啶脱氢酶(NADP)(Dihydrouracil Dehydrogenase (NADP));女(雌)性(Female);氟尿嘧啶(Fluorouracil);基因, p53(Genes, p53);头颈部肿瘤(Head and Neck Neoplasms);人类(Humans);男(雄)性(Male);中年人(Middle Aged);氧化还原酶类(Oxidoreductases);存活率(Survival Rate);胸苷酸合酶(Thymidylate Synthase);治疗结果(Treatment Outcome)
DOI
10.1038/sj.bjc.6690297
PMID
10206306
发布时间
2018-12-01
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
